Literature DB >> 3361674

Aspiration and tetracycline sclerotherapy of hydroceles.

L A Levine1, W C DeWolf.   

Abstract

Aspiration and sclerotherapy of hydroceles have been considered an effective outpatient procedure. We report on our experience with modification of this procedure in the treatment of 28 hydroceles. A 10 per cent solution of tetracycline hydrochloride was used as the sclerosant. In this series the mean followup was 15 months and there was an over-all 93 per cent success rate. A single treatment was successful in 75 per cent of the hydroceles. Complications included a hematoma in 2 patients and epididymitis in 1. We consider aspiration and sclerotherapy of hydroceles to be a reasonable alternative to an operation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361674     DOI: 10.1016/s0022-5347(17)42729-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  The use of TPA in combination with alcohol in the treatment of the recurrent complex hydrocele.

Authors:  Michael J Metcalfe; Rebecca J Spouge; David J Spouge; Chris C Hoag
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Treatment of recurrent chocolate cysts by transvaginal aspiration and tetracycline sclerotherapy.

Authors:  M A Aboulghar; R T Mansour; G I Serour; M Sattar; A M Ramzy; Y M Amin
Journal:  J Assist Reprod Genet       Date:  1993-11       Impact factor: 3.412

3.  Intraarticular minocycline injection in experimental synovitis.

Authors:  A Weinberger; T Ben-Gal; P Roizman; A Abramovici
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

4.  Percutaneous injection sclerotherapy with minocycline hydrochloride for simple renal cysts.

Authors:  M Ohkawa; S Tokunaga; M Orito; M Shimamura; S Hirano; A Okasho; S Kosaka
Journal:  Int Urol Nephrol       Date:  1993       Impact factor: 2.370

5.  Does pleurodesis for pleural effusions give bright ideas about the agents for hydrocele sclerotherapy?

Authors:  U Yilmaz; O Ekmekçioğlu; A Tatlişen; D Demirci
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.266

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.